F. Hayes et al., Functional assay for BRCA1: Mutagenesis of the COOH-terminal region reveals critical residues for transcription activation, CANCER RES, 60(9), 2000, pp. 2411-2418
The breast and ovarian cancer susceptibility gene product BRCA1 is a tumor
suppressor, but its precise biochemical function remains unknown. The BRCA1
COOH terminus acts as a transcription activation domain, and germ-line can
cer- predisposing mutations in this region abolish transcription activation
, whereas benign polymorphisms do not, These results raise the possibility
that loss of transcription activation by BRCA1 is crucial for oncogenesis.
Therefore, identification of residues involved in transcription activation
by BRCA1 will help understand why particular germ-line missense mutations a
re deleterious and may provide more reliable presymptomatic risk assessment
,
The BRCA1 COOH terminus (amino acids 1560-1863) consists of two BRCTs prece
ded by a region likely to be nonglobular. We combined site-directed and ran
dom mutagenesis, followed by a functional transcription assay in yeast: (a)
error-prone PCR-induced random mutagenesis generated eight unique missense
mutations causing loss of function, six of which targeted hydrophobic resi
dues conserved in canine, mouse, rat, and human BRCA1; (b) random insertion
of a variable pentapeptide cassette generated 21 insertion mutants, All pe
ntapeptide insertions NH2-terminal to the BRCTs retained wild-type activity
, whereas insertions in the BRCTs were, with few exceptions, deleterious; a
nd (c) site-directed mutagenesis was used to characterize five known germ-l
ine mutations and to perform deletion analysis of the COOH terminus, Deleti
on analysis revealed that the integrity of the most COOH-terminal hydrophob
ic cluster (11855, L1854, and Y1853) is necessary for activity, We conclude
that the integrity of the BRCT domains is crucial for transcription activa
tion and that hydrophobic residues may be important for BRCT function, Ther
efore, the yeast-based assay for transcription activation can be used succe
ssfully to provide tools for structure-function analysis of BRCA1 and may f
orm the basis of a BRCA1 functional assay.